Position in GRAL
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$636,959
+$214,837 QoQ
Shares Held
9,330
+14.2% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#14
of 87 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026China Universal Asset Management Co., Ltd. holds $14,326,853 across 14 Diagnostics & Research names. GRAL ranks #8 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
21,103 | $3,166,083 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
4,545 | $2,406,986 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
4,000 | $2,005,440 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
2,735 | $1,439,813 | |
| 5 | TWST |
Twist Bioscience Corp
|
9,911 | $1,019,643 | |
| 6 | NTRA |
Natera, Inc.
|
3,600 | $977,220 | |
| 7 | VCYT |
Veracyte, Inc.
|
12,699 | $745,812 | |
| 8 | GRAL |
GRAIL, Inc.
This page
|
9,330 | $636,959 |
All Filings in GRAL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $636,959 | 9,330 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $422,122 | 8,168 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $680,611 | 7,952 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $521,467 | 8,819 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $397,219 | 7,725 | Shares | Sole | 2025-08-28 | |
| 2025-03-31 | $172,139 | 6,740 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $127,181 | 7,125 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $82,174 | 5,972 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $50,751 | 3,302 | Shares | Sole | 2024-07-19 | |
| No filing history on record for this holder in this stock. | ||||||